Third's A Charm? Merck Again Faces FDA Panel To Request Mevacor Switch To OTC
FDA’s Nonprescription Drugs and Endocrinologic and Metabolic Drugs committees to review Mevacor Rx-to-OTC switch proposal Dec. 13.
FDA’s Nonprescription Drugs and Endocrinologic and Metabolic Drugs committees to review Mevacor Rx-to-OTC switch proposal Dec. 13.